Buspirone Hydrochloride Tablet
Product Images NDC 71610-962

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0962 60)

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
This text provides information on dosage options for a tablet with an initial amount of 15 mg. It outlines how much of the tablet to take to achieve doses of 10 mg, 7.5 mg, and 5 mg, indicating the corresponding fractions of the tablet to be consumed for each desired dosage.*
FDA Label Image

Figure 2 (Figure2)

FDA Label Image

Figure 3 (Figure3)

Figure 3 (Figure3)
This text provides dosage information for a tablet that can be divided into different parts to achieve the desired amount of medication. It specifies the amount of medication in milligrams for each portion of the tablet: 30 mg for the entire tablet, 20 mg for two-thirds of the tablet, 15 mg for one-half of the tablet, and 10 mg for one-third of the tablet. This information helps in accurately administering the correct dosage according to the prescribed amount.*
FDA Label Image

Figure 4 (Figure4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.